The global artemisinin combination therapy (ACT) market is entering a decade of robust expansion, projected to grow from USD 0.69 billion in 2025 to USD 1.53 billion by 2035. According to a new strategic analysis by Fact.MR, the market is advancing at an 8.3% CAGR, propelled by a global shift toward standardized first-line antimalarial protocols and aggressive...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek